NCT01046487 2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1 Completed
Clinical Trials
78 trialsNCT06856590 2025-09-15
ZINCLO-HAND
Gazi University
Phase NA Completed
NCT04258956 2025-09-11
AXAGIST
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Completed
NCT01907607 2025-08-24
CYCLIGIST
Institut Bergonié
Phase 2 Completed
NCT06038552 2025-02-26
Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM
First Affiliated Hospital, Sun Yat-Sen University
Completed
NCT00780494 2025-01-14
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
Stanford University
Phase 2 Completed
NCT06628739 2024-10-08
Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different Genotypes
First Affiliated Hospital, Sun Yat-Sen University
Completed
NCT02260505 2024-01-05
ImadGist
Centre Leon Berard
Phase 3 Completed
NCT04006769 2023-10-18
Entacapone Combination With Imatinib for Treatment of GIST
Xiangya Hospital of Central South University
Phase EARLY_PHASE1 Completed
NCT00764595 2023-07-21
GISTs
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase 2 Completed
NCT00769782 2023-07-21
GISTs
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase 2 Completed
NCT02638766 2023-03-27
REGISTRI
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Completed
NCT04476082 2023-01-25
NutriGIT
University Medicine Greifswald
Completed
NCT02712112 2023-01-04
A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs
Asan Medical Center
Phase 2 Completed
NCT03609424 2023-01-03
PDR001 Plus Imatinib for Metastatic or Unresectable GIST
Asan Medical Center
Phase 1/2 Completed
NCT05565066 2022-12-01
A Real-world Comparison of FNB and FNA in IHC-required Lesions.
Huazhong University of Science and Technology
Completed
NCT00623831 2022-10-25
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Ludwig Institute for Cancer Research
Phase 1 Completed
NCT02880020 2022-08-18
Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT03404076 2022-04-07
GISTm3
Heidelberg University
Completed
NCT02164240 2021-06-14
SURE
Dana-Farber Cancer Institute
Phase 1 Completed
NCT03158103 2021-04-30
A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01068769 2020-08-24
Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor
Dana-Farber Cancer Institute
Phase 2 Completed
NCT03880617 2020-08-10
Distress, Medication Adherence and Care Needs in Patients With CML and GIST Receiving Oral Targeted Therapy
National Taiwan University Hospital
Completed
NCT03426722 2020-07-13
L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors
Asan Medical Center
Phase 3 Completed
NCT04256226 2020-06-02
Clinical Outcome of Female Non-gastric Gastrointestinal Stromal Tumor
Far Eastern Memorial Hospital
Completed
NCT04343456 2020-04-14
Salvage Surgery for Patients With Metastatic GIST With Rego
Chang Gung Memorial Hospital
Completed
NCT01440959 2020-01-18
Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST): TKI258
Asan Medical Center
Phase 2 Completed
NCT01151852 2020-01-14
Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT
Asan Medical Center
Phase 3 Completed
NCT02889328 2020-01-09
Phase II Study of Regorafenib Continuous Dosing of Regorafenib in Patients With GISTs
Asan Medical Center
Phase 2 Completed
NCT00976612 2020-01-07
Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK
Asan Medical Center
Completed
NCT02607332 2020-01-07
Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib
Asan Medical Center
Phase 2 Completed
NCT03440515 2020-01-07
Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor
Asan Medical Center
Phase 2 Completed
NCT02931929 2019-07-19
MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT
Medical University Innsbruck
Phase 1/2 Completed
NCT00568750 2019-06-17
Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
Swiss Cancer Institute
Phase 2 Completed
NCT02606097 2019-03-21
Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation
Chang Gung Memorial Hospital
Phase 2 Completed
NCT00954655 2019-01-30
Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001
Alliance for Clinical Trials in Oncology
Completed
NCT00464620 2018-11-23
Trial of Dasatinib in Advanced Sarcomas
Sarcoma Alliance for Research through Collaboration
Phase 2 Completed
NCT01865565 2018-08-09
Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy
Chang Gung Memorial Hospital
Completed
NCT02800330 2018-08-02
REGORA
Erasmus Medical Center
Phase 4 Completed
NCT02884154 2018-01-23
Feasibility and Yield of a New 20 G ProCore Needle With Coiled Sheath in the Gastrointestinal Subepithelial Tumors
Pusan National University Hospital
Phase NA Completed
NCT01769248 2018-01-18
MUCIN
Northwestern University
Phase NA Completed
NCT01265810 2017-11-13
COMTT
Impaqtt Foundation
Phase 3 Completed
NCT03238820 2017-08-03
Robotic Resection for Patients With Gastric Gastrointestinal Stromal Tumors: a Single-center Study
Jinling Hospital, China
Phase NA Completed
NCT00654160 2017-05-25
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Mayo Clinic
Phase 1 Completed
NCT01524848 2017-05-10
PAGIST
Scandinavian Sarcoma Group
Phase 2 Completed
NCT02171286 2017-04-14
The Oncopanel Pilot (TOP) Study
British Columbia Cancer Agency
Completed
NCT01404650 2016-10-04
Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor
SCRI Development Innovations, LLC
Phase 2 Completed
NCT02877368 2016-08-24
SARCO-GIST
CHU de Reims
Completed
NCT01462994 2016-03-17
Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST)
Technical University of Munich
Phase 3 Completed
NCT02662478 2016-02-04
Laparoscopic Resection of Large Gastric Stromal Tumors
Medical Park Gaziantep Hospital
Completed